M. charantia has demonstrated promising effects in avoiding diabetes mellitus and delaying the progression of diabetic sequelae, such as neuropathy, gastroparesis, nephropathy, waterfall, and insulin blockage, in experimental animal models. The gene discussed is INS; the disease is kidney disorder.